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A B S T R A C T   
Presenilins (PS) form the active subunit of the gamma-secretase complex, which mediates the proteolytic 
clearance of a broad variety of type-I plasma membrane proteins. Loss-of-function mutations in PSEN1/2 genes 
are the leading cause of familial Alzheimer's disease (fAD). However, the PS/gamma-secretase substrates relevant 
for the neuronal deficits associated with a loss of PS function are not completely known. The members of the 
neurexin (Nrxn) family of presynaptic plasma membrane proteins are candidates to mediate aspects of the 
synaptic and memory deficits associated with a loss of PS function. Previous work has shown that fAD-linked PS 
mutants or inactivation of PS by genetic and pharmacological approaches failed to clear Nrxn C-terminal frag-
ments (NrxnCTF), leading to its abnormal accumulation at presynaptic terminals. Here, we generated transgenic 
mice that selectively recreate the presynaptic accumulation of NrxnCTF in adult forebrain neurons, leaving 
unaltered the function of PS/gamma-secretase complex towards other substrates. Behavioral characterization 
identified selective impairments in NrxnCTF mice, including decreased fear-conditioning memory. Electro-
physiological recordings in medial prefrontal cortex-basolateral amygdala (mPFC-BLA) of behaving mice showed 
normal synaptic transmission and uncovered specific defects in synaptic facilitation. These data functionally link 
the accumulation of NrxnCTF with defects in associative memory and short-term synaptic plasticity, pointing at 
impaired clearance of NrxnCTF as a new mediator in AD.   
1. Introduction 
Neurexins (Nrxns) form a large family of presynaptic adhesion pro-
teins that couple neurotransmitter release and trans-synaptic in-
teractions with postsynaptic ligands (Dean et al., 2003; Südhof, 2017). 
Genetic studies and analysis of protein levels in peripheral samples from 
patients suggest a role for altered Nrxn levels in preclinical and clinical 
stages of Alzheimer's disease (AD) (Duits et al., 2018; Goetzl et al., 2018; 
Lleó et al., 2019; Martinez-Mir et al., 2013). Nrxns are subject to regu-
lation at several levels. At the transcriptional level, the use of alternative 
promoters together with extensive alternative splicing generates hun-
dreds of isoforms that differ at the extracellular domain (Gomez et al., 
2021; Schreiner et al., 2014; Treutlein et al., 2014). Proteolytic cleavage 
is emerging as a new post-translational mechanism that regulates Nrxn 
function (Saura et al., 2011; Servián-Morilla et al., 2018). Proteolytic 
regulation of Nrxns proceeds in two sequential steps. First, a cleavage in 
the juxtamembrane region releases the specific ectodomain of the pro-
cessed isoform and generates a common membrane-bound Nrxn C-ter-
minal fragment (NrxnCTF) (Saura et al., 2011). Subsequently, NrxnCTF 
is cleared by Presenilins (PS), the active subunit of the gamma-secretase 
complex, which mediates the intramembrane cleavage of a number of 
substrates (Bot et al., 2011; Saura et al., 2011; Servián-Morilla et al., 
2018). Importantly, mutations in PSEN1/2 genes are the main cause of 
familial AD (fAD) explaining about 90% of fAD cases (Cacace et al., 
2016). 
Several findings support that fAD-linked PSEN mutations act trough 
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a loss-of-function mechanism (De Strooper, 2007; Shen and Kelleher 
3rd, 2007; Wolfe, 2007). In a seminal study, Shen and collaborators 
showed that conditional mice lacking PS1/2 genes in adult forebrain 
neurons (PScKO mice) develop key symptoms resembling AD, including 
early and progressive deficits in synaptic plasticity and memory, fol-
lowed by late synapse loss, neurodegeneration and hyper-
phosphorylation of Tau proteins (Saura et al., 2004). Biochemical 
evaluation of fAD-associated gamma-secretase complexes and the gen-
eration of mouse models recapitulating fAD-linked PSEN1 mutations 
have further supported the loss-of-function hypothesis for PS in AD (Sun 
et al., 2017; Xia et al., 2015; Zhou et al., 2017). As such, loss of PS 
function results in decreased gamma-secretase activity inducing the 
accumulation of its proteolytic substrates in a context-dependent 
manner. Thus, the accumulation of a particular substrate coinciding 
with the onset of symptoms helps to define potential candidates asso-
ciated with impaired PS function. However, the high number of sub-
strates for PS/gamma-secretase challenges the identification of single 
candidates with a functional relevance in the loss of PS function (Güner 
and Lichtenthaler, 2020; Haapasalo and Kovacs, 2011). Therefore, the 
PS/gamma-secretase substrates that can produce key synaptic and 
memory defects associated with a loss of PS function are not completely 
known. 
Nrxns are candidates to mediate aspects of the synaptic and behav-
ioral deficits caused by loss of PS/gamma-secretase function. It has been 
previously shown that chemical or genetic inhibition of PS/gamma- 
secretase activity results in the accumulation of NrxnCTF in vitro and 
in vivo (Bot et al., 2011; Saura et al., 2011). Moreover, the clearance of 
NrxnCTF is inhibited in cells expressing fAD-associated PSEN1 muta-
tions, suggesting that NrxnCTF accumulates in fAD (Bot et al., 2011; 
Saura et al., 2011). In vivo, NrxnCTF accumulates at presynaptic termi-
nals of PScKO mice at a time coinciding with the onset of synaptic and 
behavioral deficits but prior to neurodegeneration (Saura et al., 2011). 
Importantly, the sole expression of NrxnCTF in cultured hippocampal 
neurons while maintaining PS function mimics the deficits in neuro-
transmitter release and calcium influx caused by the absence of PS1/2 
genes or gamma-secretase activity (Servián-Morilla et al., 2018). 
Although these findings suggested a role for the impaired synaptic 
clearance of NrxnCTF in the loss of PS function, the deficits produced by 
the brain accumulation of NrxnCTF are currently unknown. 
In this study, we generated transgenic mice that selectively accu-
mulate NrxnCTF in adult forebrain neurons. Biochemical characteriza-
tion showed that NrxnCTF mice recapitulate the distribution of NrxnCTF 
found in conditional mice lacking PS1/2 function in the forebrain. 
However, PS/gamma-secretase function towards other substrates is not 
affected in NrxnCTF mice. Importantly, we found that the selective 
accumulation of NrxnCTF produces behavioral deficits, including 
decreased fear-conditioning memory. Electrophysiological recordings in 
alert behaving mice revealed impaired short-term synaptic plasticity at 
mPFC-BLA synapses of NrxnCTF mice, in line with the presence of a 
putative presynaptic mechanism. These data indicate that the impaired 
synaptic clearance of NrxnCTF caused by a loss of PS function leads to 
synaptic plasticity and behavioral deficits in mature brain. 
2. Materials and methods 
2.1. Generation of transgenic NrxnCTF mice 
The HA-NrxnCTF construct contains a signal peptide followed by a 
HA tag and the last 85C-terminal residues of human Nrxn1. A DNA 
fragment containing the TRE promoter, the coding sequence of HA- 
NrxnCTF and a WPRE fragment (woodchuck hepatitis virus post-
transcriptional regulatory element) was injected into the pronucleus of 
FVB/N zygote for transgenic mouse production. TRE-NrxnCTF mouse 
lines were mated with CaMKIIα-tTA mice (Mayford et al., 1996) in a 
C57BL/6 J background. Doxycycline (DOX) was provided in the diet 
(SAFE, 40 mg/kg). PScKOtam mice were generated by crossing fPS1/ 
fPS1;PS2− /− with CaMKIIα-CreERT2 mice (Erdmann et al., 2007). 
Generation and characterization of fPS1/fPS1;PS2− /− mice have been 
previously described (Saura et al., 2004; Shen et al., 1997). Animals 
were kept at 22 ◦C on a 12 h dark/light cycle and food and water were 
provided ad libitum. Mice were used according to animal care standards 
and all protocols were approved by the Committee of Animal Use for 
Research at the University of Seville (Spain). 
2.2. Biochemical analysis 
Forebrain tissues were homogenized in lysis buffer (50 mM Tris-HCl 
pH 7.4; 100 mM NaCl; 5 mM MgCl2; 1% Triton X-100 and 0.1% SDS) 
containing a protease inhibitor cocktail (Roche). Synaptosome fractions 
were isolated as previously described (Carlin et al., 1980; Saura et al., 
2011). In brief, tissues from 5-6-month-old mice (three animals per 
preparation) were homogenized with a Teflon-glass homogenizer in 
buffer A (5 mM HEPES pH 7.4, 0.32 M sucrose, 1 mM NaHCO3, 1 mM 
MgCl2, 0.5 mM CaCl2, 0.1% NP-40) supplemented with protease and 
phosphatase inhibitors cocktail (Sigma). The resulting homogenate (L 
fraction) was centrifuged at 1400g for 10 min. The supernatant was 
saved (S1) and the pellet was further homogenized in buffer A and 
centrifuged at 710g for 10 min. The supernatants (S1 and S2) were 
combined and centrifuged (13,800 g for 10 min). The pellet was resus-
pended in buffer B (6 mM Tris HCl pH 8.0, 0.32 M sucrose, 1 mM 
NaHCO3, 0.1% NP40, with phosphatase and protease inhibitors), ho-
mogenized (M fraction) and loaded on top of an ice-cold discontinuous 
sucrose gradient (1.2 M, 1 M and 0.85 M) and centrifuged at 82,500 g for 
2 h. Synaptosome fraction (S fraction) was collected from the interface 
between 1 M and 1.2 M layers, diluted in buffer C (12 mM Tris pH 8.0, 
1% Triton X-100, with phosphatase and protease inhibitors) and incu-
bated on ice for 15 min. The suspension was centrifuged at 32,800 g for 
1 h. The supernatant was collected (presynaptic fraction) and the pellet 
was resuspended and sonicated in buffer D (40 mM Tris pH 8.0, 1% NP- 
40, with phosphatase and protease inhibitors) to obtain the postsynaptic 
fraction. All steps were performed at 4 ◦C. Fractions were aliquoted, 
frozen in liquid N2 and stored at − 80 ◦C. Protein concentration was 
determined with the BCA protein assay kit (Pierce). 
Western blot experiments of lysates containing equal-protein loading 
(15-40 μg per lysate) were performed using the following primary an-
tibodies: rat anti-HA (1:500, Roche), rabbit anti-Neurexin 1,2,3 (1:500, 
Synaptic Systems), mouse anti-PSD95 (1:1000, ThermoScientific), 
mouse anti-SNAP25 (1:2000, Sigma Aldrich) and mouse anti-β actin 
(1:5000, Sigma Aldrich). Immunoreactivity was detected with appro-
priate secondary antibodies conjugated with horseradish peroxidase 
(1:5000, Jackson ImmunoResearch). Chemiluminescence was devel-
oped using Clarity ECL Substrate (Bio-Rad) or Clarity Max ECL Substrate 
(Bio-Rad) on an ImageQuant LAS4000 Mini (GE Healthcare Life 
Sciences). 
2.3. Behavioral analysis 
Behavioral studies were performed in two independent cohorts of 
male NrxnCTF and littermate control (wild-type, TRE-NrxnCTF and 
CaMKIIα-tTA) mice of the same age (5–8 months). To elude early 
transgene expression, all mice were fed with diet with DOX from 
gestation to 30 days after birth. Mice were caged in the behavioral room 
for 30 min before the behavioral examination. Tests were carried out 
from 9 a.m. to 6 p.m. All behavioral tasks and quantification analysis 
were performed by researchers blind to the genotype of the mice. 
2.4. Open field test 
The tested mouse was allowed to freely explore a square open field 
arena (45 × 45 cm, Harvard Apparatus) for 15 min. Automatic detection 
of the mouse, total travelled distance and time spent in the central zone 
(20 cm apart from the walls) were recorded with the Smart software 
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Stereotyped behavior was studied with the self-grooming test. Mice 
were placed in a clean cage without bedding. After 10 min of habitua-
tion, behavior was video-recorded for 10 min. Time spent in self- 
grooming and numbers of bouts were manually quantified. 
2.6. Three-chamber test 
The test was performed as described previously (Silverman et al., 
2010) with minor modifications. A social interaction box (Harvard 
Apparatus) divided in 3 compartments was used. The social arena was 
made of a transparent box (42 × 60 cm) with two transparent sliding 
doors that divide left, right and center chambers (42 × 20 cm). In the 
first 10-min session, the tested mouse was placed in the central chamber 
with the sliding doors closed. Then, a 10-min habituation session pro-
ceeded where the tested mouse had access to the sided chambers, con-
taining two empty circular cages (8 cm diameter). After habituation, 
circular cages housing an unfamiliar C57BL/6 J mouse of the same sex 
and age or an inanimate object (plastic cube) was located in the corners 
of the left or right chambers. A cylindrical bottle filled with water was 
placed on top of the enclosures to prevent the tested mouse from 
climbing. The tested mouse was located in the central chamber and 
allowed to explore the arena for 10 min. The location of the cages was 
alternated between tests. Tests were video-recorded and the number of 
transitions between compartments was automatically registered with 
the Smart software. Time spent in close contact with the cages was 
manually measured. 
2.7. Novel object recognition and Barnes maze tests 
The tested mouse was placed in the center of the open field arena and 
allowed to freely explore the area for 15 min. Following habituation to 
the arena, two identical objects were placed in opposite corners, 15 cm 
apart from the walls. The tested mouse was placed back in the center of 
the field and allowed to explore the area for 10 min. After 24 h, one of 
the familiar objects was replaced for a new object of different size, 
colour and shape. Then, the tested mouse was placed in the arena and 
allowed to explore the area for 10 min. The location of the new object 
was alternated between assays. The test was video-recorded and the 
time spent interacting with the objects was manually measured. 
The Barnes maze assay was performed as previously described 
(Andrade-Talavera et al., 2015). Briefly, mice were located on top of an 
elevated round platform (Harvard Apparatus) delimited by 20 evenly 
spaced holes in the periphery. To assess spatial memory, visuo-spatial 
cues were located hanging on panels in the proximity surrounding the 
platform. During learning, all holes but one, the escape hole, were 
covered and mice were exposed to the platform. Bright light and 
standing fans serve as motivating factors to induce scape behavior. The 
escape hole is maintained at a fixed location for the duration of training, 
which involves four daily trials (maximum time to find the escape hole: 
180 s per trial). In unsuccessful trials, mice were gently guided to the 
escape hole at the end of the trial. Twenty-four hours and eight days 
after training, mice were tested in a single session of 90 s in the same set- 
up with all holes covered. The time in reaching the escape hole and spent 
in each quadrant was automatically quantified (SMART software). 
2.8. Fear conditioning test 
The contextual and auditory fear-conditioning test was evaluated in 
a test box (Harvard Apparatus). Mice were allowed to freely explore the 
test box for 2 min before they were exposed to conditioning phase 
consisting of three repetitions of a 30 s tone co-terminating for 2 s with a 
mild electric shock (0.2 mA). After 24 h, mice were placed in the same 
conditioning room for 5 min (contextual phase). Then, mice were 
exposed to three repetitions of the tone but in a different shaped 
chamber and without a shock. Freezing response during the tests was 
detected with sensors located in the floor. Packwin software was used to 
automatically analyze the freezing response. 
2.9. Surgery 
For electrode implantation, mice were anaesthetized with 1–2% 
isoflurane, supplied from a calibrated Fluotec 5 (Fluotec-Ohmeda, 
Tewksbury, MA, USA) vaporizer, at a flow rate of 1–2 L/min oxygen 
(AstraZeneca, Madrid, Spain) and placed into a stereotaxic frame. 
Additional anesthesia was delivered by a special mouse mask (David 
Kopf Instruments, Tujunga, CA). Animals were implanted with a bipolar 
stimulating electrode in the medial prefrontal cortex (mPFC) (1.8 mm 
rostral to Bregma; 0.3 mm lateral; and 2 mm deep from the brain's 
surface) (Franklin and Paxinos, 2007) and a bipolar recording electrode 
in the basolateral amygdala (BLA) (1.8 mm posterior to Bregma; 3 mm 
lateral; and 3.9 mm deep from the brain's surface). Electrodes were 
made of 50 μm, Teflon-coated, tungsten wires (Advent Research, Eyn-
sham, UK) and their tip were bared of their isolating cover for 0.5 mm. 
Two screws, each one connected to a bare silver wire, were affixed to the 
skull as a ground. The six wires were soldered to a 6-pin socket (RS 
Amidata, Madrid, Spain), which was covered and fixed to the brain with 
dental cement. Further information about this experimental procedure is 
detailed elsewhere (Gruart et al., 2006). After surgery, animals recov-
ered for a week before the start of the recording sessions. 
2.10. Stimulation and recording procedures 
Recording sessions were carried out in 6 mice at a time. Animals 
were placed in individual small (5 cm × 5 cm × 10 cm) plastic chambers 
located inside a larger Faraday box (30 cm × 30 cm × 20 cm). Field 
excitatory postsynaptic potentials (fEPSPs) were evoked with the help of 
Cibertec CS20 stimulators (Cibertec, Madrid, Spain) and recorded with 
Dagan Corporation EX4-400 Quad Differential amplifiers (Dagan Cor-
poration, Minneapolis MN USA) at a bandwidth of 0.1 Hz-10 kHz, 
through a high-impedance probe (2 × 1012 Ω, 10 pF). 
2.11. Paired-pulse facilitation and input/output curves 
Input/output curves were tested with paired pulses (40 ms of inter- 
stimulus interval) of increasing intensities (0.02–0.4 mA, in steps of 
0.02 mA). Animals received ten pulses for each intensity, which were 
averaged in order to measure the evoked fEPSP amplitude. For the 
paired-pulse facilitation test, 17 mice were stimulated with paired pulses 
of different inter-stimulus intervals (10, 20, 40, 100, 200 and 500 ms; 
ten pulses each) with intensities corresponding to 40% of the intensity 
necessary to evoke a saturating fEPSP response. 
2.12. Long-term potentiation 
Baseline recordings were carried out for 15 min prior to the LTP 
induction. Field EPSPs were evoked with paired (40 ms inter-stimulus 
interval) 100 μs squared, biphasic pulses at a rate of 3/min (0.05 Hz). 
Pulse intensity was set at 40% of the amount necessary to evoke a 
maximum fEPSP response (0.05–8.0 mA) (Gruart et al., 2006; Gur-
eviciene et al., 2004). LTP was induced by applying a high-frequency 
stimulation (HFS) protocol, which consisted of five 100 ms trains of 
pulses at a frequency of 200 Hz presented at a rate of one per second. 
This protocol was presented 6 times (1/min). In order to avoid evoking 
large population spikes and/or the appearance of EEG seizures, the 
stimulus intensity during the HFS was set at the same value as that used 
for generating baseline recordings. None of the animals used in this 
study presented any after-discharge or motor seizure following the HFS 
protocol, as checked by on-line EEG recordings and visual observation of 
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the stimulated mouse (Madroñal et al., 2009). After the induction, 
fEPSPs were recorded with the same procedure of the baseline along 
four sessions (1 h in day 1 and 30 min in days 2–4). Field EPSP amplitude 
was measured in the recordings before and after evoking long-term 
potentiation (LTP) and represented as a percentage of the base line 
(taken as a 100%), calculating the average of 15 pulses for each 5 min 
interval. 
2.13. Histology 
At the end of the recording sessions, mice were deeply anaesthetized 
(sodium pentobarbital, 50 mg/kg) and perfused transcardially with 
0.9% saline followed by fixation with 4% paraformaldehyde in 
phosphate-buffer (PFA). Brains were removed from the skull and 
maintained in PFA overnight at 4 ◦C and cryoprotected with an 
increasing gradient (5–30%) of sucrose in PBS. 50 μm brain slices was 
obtained with a cryotome (Leica, Wetzlar, Germany). Brain sections 
with the structures of interest were mounted on gelatinized glass slides 
and stained using a Nissl technique (0.1% Toluidine Blue). Micrographs 
of the electrode scar were taken with a light microscope. 
2.14. Data collection and analysis 
Behavioral tests were video-recorded and manually or automatically 
quantified and data were analyzed using one-way ANOVA with Tukey 
post-hoc test. Field EPSPs were stored digitally on a computer through 
the analogue/digital converter CED 1401 Plus (CED, Cambridge, En-
gland), at a sampling frequency of 5 kHz with an amplitude resolution of 
16 bits. Data were analyzed off-line for fEPSP amplitude with the help of 
CED Spike 2 and Signal (Systat Software, San Jose, CA, USA) programs. 
For this, 15 successive fEPSPs were averaged every 5 min to quantify 
EPSP amplitudes. Results were represented with Microsoft Excel 
(Microsoft, Redmon, WA, USA) and CorelDraw (Corel Corporation, 
Ottawa, Canada) programs and computed and processed for statistical 
analysis using the Sigma Stat for Windows package. Regression analyses 
were used to study the relationship between LTP and paired-pulse var-
iables (Student's t-test). Unless otherwise indicated, data are represented 
as the mean ± SEM. Acquired data were analyzed using a two-way 
ANOVA, with sessions as repeated measure. Contrast analysis was 
added for a further study of significant differences. 
3. Results 
3.1. Generation of mice expressing NrxnCTF in the forebrain 
The accumulation of NrxnCTF in mice lacking PS1/2 genes in the 
adult forebrain suggests a contribution of the impaired processing of 
Nrxns in the neuronal defects caused by a loss of gamma-secretase 
function. However, the broad accumulation of substrates following in-
hibition of PS/gamma-secretase activity avoids the identification of 
single substrates with a functional impact. To face this limitation, we 
have developed transgenic mice that selectively accumulate NrxnCTF in 
Fig. 1. Generation of NrxnCTF transgenic mice. A) Schematic drawings showing the proteolytic processing of Nrxns by metalloproteases and PS (left) and the HA- 
tagged NrxnCTF transgene used in this study (right). The regions recognized by the HA and the cyto-Nrxn antibodies are indicated. LNS, Laminin/Neurexin/Sex 
hormone binding-globulin domain; TM, transmembrane region. B) Representation showing the genetic approach for the expression of NrxnCTF in the forebrain. C) 
Expression of NrxnCTF in forebrain tissues of NrxnCTF mouse lines. NrxnCTF expression was analyzed in cortex, hippocampus and striatum by Western-blot ex-
periments with HA and cyto-Neurexin antibodies, as indicated. Lysates from single transgenic CaMKIIα-tTA and TRE-NrxnCTF mouse lines were analyzed as 
additional controls. 
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the adult forebrain (Fig. 1). Mutagenesis analysis has previously showed 
that the last 85C-terminal residues of Nrxn1 represent the NrxnCTF 
substrate for PS/gamma-secretase (Servián-Morilla et al., 2018). 
Therefore, we generated a cDNA encoding NrxnCTF tagged at the N- 
terminus with an HA epitope to allow detection (Fig. 1A). The NrxnCTF 
construct was cloned under the control of the tetracycline-responsive 
element (TRE) (Fig. 1B). Two transgenic TRE-NrxnCTF mouse lines 
were obtained by nuclear injection, lines B and C. Transgene expression 
from the TRE promoter requires the co-expression in the same cells of 
the tetracycline transactivator (tTA). In PScKO mice, conditional dele-
tion of PS genes in forebrain is achieved by the activity of a CaMKIIα 
promoter (Saura et al., 2004). Similarly, we chose a CaMKIIα-tTA allele 
to drive NrxnCTF expression in forebrain neurons (Mayford et al., 1996). 
Thus, we aimed at accumulating NrxnCTF with the same distribution 
than a loss of PS function would produce in forebrain neurons, but 
leaving PS/gamma-secretase activity unaltered (Fig. 1B). Double 
transgenic CaMKIIα-tTA;TRE-NrxnCTF mice (termed NrxnCTF mouse 
lines for simplicity) were born at the expected ratio. Expression of 
NrxnCTF was analyzed in lysates of forebrain regions by Western-blot 
experiments. The HA antibody recognized a major band of 14 kDa in 
lysates from hippocampus, cortex and striatum of NrxnCTF mice of line 
B (Fig. 1C). However, NrxnCTF was undetectable in the hippocampus 
and cortex of line C, and low expression levels were found at the stria-
tum of the same line (Fig. 1C). A similar pattern of NrxnCTF expression 
was found in both mouse lines with an antibody that recognizes the 
common cytoplasmic tail of Nrxns, although a minor band of a lower 
mobility was more clearly detected in the transgenic mouse lines 
(Fig. 1C). In contrast, the HA antibody did not detect ectopic NrxnCTF 
expression in single transgenic mice (Fig. 1C), indicating the absolute 
requirement of the CaMKIIα-tTA driver for transgene expression. 
Notably, the expression pattern of NrxnCTF in line B recapitulates the 
accumulation of endogenous NrxnCTF in mice lacking PS function in the 
forebrain (Saura et al., 2011) (see below). Based on these data, we 
selected NrxnCTF mice from line B for further experiments. 
3.2. Synaptic expression of NrxnCTF in adult forebrain 
It has been reported that the CaMKIIα-tTA driver can promote 
transgene expression during pre- or early postnatal development 
(Nicholls et al., 2008; Roberts et al., 2009). This early expression might 
result in confounding effects when the impact of the transgene in the 
mature brain is upon evaluation (Rodgers et al., 2012), such in this 
study. We took advantage of the temporal-regulation provided by the 
Tet-off system to strictly limit the expression of NrxnCTF to adult fore-
brain. With this aim, we mated single transgenic CaMKIIα-tTA and TRE- 
NrxnCTF mice in the presence of diet with DOX and maintained the 
parental mice and their progeny in this diet until weaning, at postnatal 
day 30 (P30) (Fig. 2A). This time point matches the time at which PS 
gene deletion was reported in PScKO mice (Saura et al., 2004). As shown 
in Fig. 2B, this strategy results in the adult onset expression (>P30) of 
NrxnCTF at similar levels than untreated NrxnCTF mice. 
Then, we interrogated if transgenic NrxnCTF recapitulates the 
expression at presynaptic terminals of synaptosome preparations pre-
viously described for the endogenously produced NrxnCTF in PScKO 
mice (Saura et al., 2011). In Western blot experiments of synaptosome 
preparations, transgenic NrxnCTF was found at synaptic fractions, 
where it concentrates at presynaptic, but not postsynaptic, terminals of 
cortex and hippocampus (Fig. 2C). The distribution of the synaptic 
markers PSD95 and SNAP25 within the post- and presynaptic fractions, 
respectively, confirmed the isolation protocol (Fig. 2C). These data 
indicate successful accumulation of NrxnCTF at presynaptic terminals of 
adult forebrain neurons once the formation of the synaptic circuitry is 
completed. 
Fig. 2. Adult onset expression and distribution in synaptosome fractions from forebrain regions of NrxnCTF. A) Temporal control of NrxnCTF expression with DOX. 
B) Western-blot experiments showing NrxnCTF expression in adult forebrain of transgenic mice at different times after DOX removal at P30 (on/off). For comparison, 
NrxnCTF expression of untreated mice (No DOX) was analyzed for comparison. C) Synaptosome preparations from cortex and hippocampus of NrxnCTF mice were 
incubated with HA, SNAP25 and PSD95 antibodies, as shown. L, lysate; SN, supernatant; Mb, membrane; S, synaptosome; Pre, presynaptic fraction and Post, 
postsynaptic fraction. HA antibody detects the expression of NrxnCTF in presynaptic fractions of forebrain tissues. 
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3.3. Normal PS/gamma-secretase activity in NrxnCTF mouse 
Our approach based on the selective accumulation of NrxnCTF aims 
at preserving PS levels and gamma/secretase function towards other 
substrates. To obtain experimental support for this hypothesis, we 
analyzed PS1 levels and the expression of representative PS substrates in 
lysates from NrxnCTF mice. To establish suitable comparisons for these 
experiments, we obtained mice with loss of PS function in adult fore-
brain neurons. For that, we mated PS1f/f;PS2− /− mice with transgenic 
CaMKIIα-CreERT2 mice to obtain PS1f/f;PS2− /− ;CaMKIIα-CreERT2 
mice. Then, Cre activity was induced with Tamoxifen at P30 to generate 
PScKOtam mice. As a surrogate for the loss of PS function, we first 
analyzed the production of APP-CTF in PScKOtam mice at different times 
after treatment with Tamoxifen. As shown in Fig. 3A, APP-CTF levels 
clearly increased in PScKOtam mice from one to four months after 
treatment, indicating effective loss of PS function. Then, we selected for 
comparison PScKOtam and NrxnCTF mice at 4.5 months, allowing for the 
same time after PS gene deletion and NrxnCTF expression, respectively. 
The levels of PS1 were reduced in the forebrain of PScKOtam mice 
compared with controls, as expected (Fig. 3B, C). The remaining PS1 
levels detected in PScKOtam mice likely represent PS1 expression in 
CaMKIIα-promoter inactive neurons and in non-neuronal cells (Saura 
et al., 2004). By contrast, the expression of PS1 was not altered in 
NrxnCTF mice (Fig. 3B, C). Moreover, whereas N-Cadherin-CTF and 
APP-CTF accumulated in PScKOtam mice, neither of these PS/gamma- 
secretase substrates showed accumulation in NrxnCTF mice. These 
data suggest that the levels and the proteolytic activity of the PS/ 
gamma-secretase complex towards its substrates are not broadly 
affected by the expression of NrxnCTF. 
As a further characterization of the mouse model, we decided to 
compare the expression of transgenic NrxnCTF with NrxnCTF produced 
in PScKOtam mice. For that, Western blot experiments were performed 
with an antibody that recognizes the common cytoplasmic tail of Nrxns 
(Fig. 1). As expected, loss of PS function in PScKOtam mice produced the 
accumulation of NrxnCTF in cortex and hippocampus (Fig. 3B, C). 
Importantly, the cyto-Nrxn antibody detected NrxnCTF proteins in 
Fig. 3. Normal PS function in NrxnCTF mice. A) Accumulation of APP-CTF in hippocampal and cortical lysates of PScKOtam mice at different times after PS deletion. 
NrxnCTF mice do not accumulate APP-CTF, as shown. B) Expression of PS1 and of selected PS/gamma-secretase substrates in PScKOtam and NrxnCTF mice. Cortical 
and hippocampal lysates were analyzed by Western-blot with PS1, APP, N-Cadherin and cyto-Nrxn antibodies, as indicated. The cyto-Nrxn antibody recognizes the 
cytoplasmic tail of both endogenously produced NrxnCTF in PScKOtam mice and NrxnCTF expressed in transgenic mice. Note that expression of PS1 or accumulation 
of gamma-secretase substrates are not affected in NrxnCTF mice. 
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transgenic mice with a similar pattern and tissue distribution than 
NrxnCTF accumulated in PScKOtam mice (Fig. 3B, C). The level of 
NrxnCTF expression in transgenic mice was 4-5-fold higher than those of 
NrxnCTF in PScKOtam mice, indicating moderate over-expression. A 
recent work failed to uncover accumulation of NrxnCTF in neurons 
lacking PS function (Barthet et al., 2018). While the reasons for these 
results are not known, detection of Nrxn proteins have been proved 
difficult and require proper immunological tools (Dean et al., 2003). Our 
experiments using different brain regions of mice lacking PS further 
confirm the accumulation of NrxnCTF. Collectively, the biochemical 
characterization indicate that NrxnCTF mice reproduce the impaired 
clearance of the Nrxn substrate for PS with the same tissue distribution 
and subcellular localization than a loss of PS function would generate in 
adult forebrain neurons, but leaving intact PS/gamma-secretase func-
tion towards other substrates. 
3.4. Decreased stereotyped behavior and subtle social interaction deficits 
in NrxnCTF mice 
NrxnCTF mice represent a suitable animal model to study the effects 
produced by a selective loss of PS/gamma-secretase function towards 
Nrxns. First, we conducted a battery of tests to uncover potential 
behavioral deficits. Within each test, NrxnCTF mice were compared with 
two types of controls, one control group comprised by wild-type and 
TRE-NrxnCTF mice and a second control group formed by CaMKIIα-tTA 
mice. These comparisons rule out any potential contribution that the 
CaMKIIα-tTA allele might cause in the phenotypes under study (Han 
et al., 2012). Locomotion was analyzed in the Open Field assay. Total 
distance as well as the distance travelled at the periphery and at the 
center were found similar in NrxnCTF mice and control groups (Fig. 4A), 
indicating that locomotion is not affected in NrxnCTF mice. 




























































































































































Fig. 4. Locomotion, repetitive behavior and social interaction in NrxnCTF mice. A) Open field assay. Total distance and distance travelled per area are shown. Total 
distance: control 5893 ± 273.7; CaMKIIα-tTA 5008 ± 450.4; NrxnCTF 6509 ± 705.3. Distance at the periphery: control 4892 ± 218.2; CaMKIIα-tTA 4374 ± 406.9; 
NrxnCTF 5569 ± 625.2. Distance at the center: control 1001 ± 86.29; CaMKIIα-tTA 634.1 ± 83.31; NrxnCTF 940.5 ± 120. Distance in cm. Control, n = 29; CaMKIIα- 
tTA, n = 15; NrxnCTF, n = 24. B) Reduced self-grooming time in NrxnCTF mice compared with control groups. Control 67.10 ± 10.09; CaMKIIα-tTA 72.10 ± 13.29; 
NrxnCTF 28.31 ± 5.19. Time in s. Control, n = 28; CaMKIIα-tTA, n = 14; NrxnCTF, n = 24. C) Social interaction in the three-chamber test. Graphs show total time 
spent in interaction with the mouse and the object (left), time interacting with the mouse or the object (center) and social index (left). Total interaction time: control 
156.0 ± 10.77; CaMKIIα-tTA 140.5 ± 11.86; NrxnCTF 152,7 ± 12,13. Time interacting with the object: control 36.19 ± 5.20; CaMKIIα-tTA 35.51 ± 4.92; NrxnCTF 
53.61 ± 9.08; time interacting with the mouse: control 119.8 ± 9.26; CaMKIIα-tTA 105.0 ± 12.42; NrxnCTF 99.05 ± 12.85. Time in s. Social index: control 26.18 ±
2.99; CaMKIIα-tTA 23.43 ± 4.15; NrxnCTF 14.46 ± 4.93. Control, n = 17; CaMKIIα-tTA, n = 12; NrxnCTF, n = 12. ** p < 0.01, *** p < 0.001. 
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associated with AD, including altered stereotypic behavior and social 
apathy (Bozeat et al., 2000; Cerejeira et al., 2012; Prioni et al., 2012). 
Repetitive behavior was studied in the self-grooming assay in which the 
time dedicated to perform a stereotyped sequence of movements is 
quantified (Fig. 4B). Interestingly, self-grooming time in NrxnCTF mice 
was decreased by over 50% as compared with control and CaMKIIα-tTA 
mice (Fig. 4B). The number of self-grooming bouts was similar in the 
three groups (control: 3.71 ± 0.38; CaMKIIα-tTA: 4.42 ± 0.74; NrxnCTF: 
3.41 ± 0.32; p > 0,05), but NrxnCTF mice showed shorter duration of 
self-grooming events (control: 19.64 ± 3.09; CaMKIIα-tTA: 18.76 ±
3.70; NrxnCTF: 9.02 ± 1.71; p < 0.01; time in s). Social interaction was 
evaluated in the three-chamber test (Fig. 4C). In this assay, the tested 
mouse is placed in a middle chamber and the time interacting with an 
inanimate stimulus or with a mouse located in side chambers is 
analyzed. Total interaction time with either of the two stimuli was found 
similar in the three animal groups (Fig. 4C). Furthermore, NrxnCTF mice 
showed preferential interaction with the mouse compared with the ob-
ject, although the average time interacting with the object slightly 
increased in NrxnCTF mice as compared with control groups, without 
reaching statistical significance (Fig. 4C). This trend towards decreased 
social interaction in NrxnCTF mice was detected with the social index, 
which measures the percentage of time that each animal differentially 
interacts with the mouse (Fig. 4C). These findings indicate that expres-
sion of NrxnCTF in adult forebrain produces decreased stereotyped 
behavior and subtle deficits in social interaction. 
3.5. Normal recognition memory and spatial memory in NrxnCTF mice 
Memory deficit is a core symptom in AD and mouse models lacking 
PS expression. Therefore, we analyzed the performance of NrxnCTF 
mice in several memory assays. The novel object recognition test eval-



























































































Fig. 5. Normal spatial and recognition memories in NrxnCTF mice. A) Novel object recognition. Similar average time interacting with the familiar or novel object in 
NrxnCTF mice compared with control groups. Control, familiar object 39.86 ± 3.75%, novel object 60.14 ± 3.75%; CaMKIIα-tTA, familiar object 33.42 ± 4.22%, 
novel object 66.58 ± 4.22%; NrxnCTF, familiar object 36.79 ± 2.74%, novel object 63.21 ± 2.74%. Control, n = 17; CaMKIIα-tTA, n = 5; NrxnCTF, n = 11. B-D) 
Barnes maze test. B) Time latency to find the escape hole during the four training sessions. Control 64.72 ± 6,35, 57.11 ± 6.73, 51.19 ± 8.71, 38.91 ± 5.54; CaMKIIα- 
tTA 93.00 ± 14.65, 80.9 ± 15.41, 59.97 ± 8.16, 38.53 ± 6.15; NrxnCTF 68.94 ± 11.47, 42.12 ± 6.07, 30.79 ± 5.06, 33.28 ± 6.28. Time in s. C) Percentage of time 
spent in quadrant one day after training. Adjacent -, control 20.28 ± 3.23%, CaMKIIα-tTA 26.69 ± 10.34%, NrxnCTF 16.54 ± 3.12%; target, control 52.22 ± 5.22%, 
CaMKIIα-tTA 48.99 ± 11.06%, NrxnCTF 42.39 ± 6.23%; adjacent +, control 19.13 ± 3.68%, CaMKIIα-tTA 17.96 ± 7.96%, NrxnCTF 27.76 ± 6.46%; opposite, 
control: 8.36 ± 1.47%, CaMKIIα-tTA: 6.36 ± 1.74%, NrxnCTF 13.32 ± 2.55%. D) Percentage of time spent in quadrant eight days after training. Adjacent-, control 
10.74 ± 1.97%, CaMKIIα-tTA 4.08 ± 1.35%, NrxnCTF 8.60 ± 2.19%; target, control 44.74 ± 5.89%, CaMKIIα-tTA 55.90 ± 11.20%, NrxnCTF 51.57 ± 8.16%; 
adjacent +, control 19.29 ± 2.89%, CaMKIIα-tTA 24.60 ± 10.19%, NrxnCTF 18.91 ± 5.82%; opposite, control 14.99 ± 3.13%, CaMKIIα-tTA 7.31 ± 3.14%, NrxnCTF 
11.02 ± 2.32%. Control, n = 18; CaMKIIα-tTA, n = 12; NrxnCTF, n = 12. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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presented along a familiar one. NrxnCTF mice showed no differences 
with control groups in the preferential interaction with the novel object 
(Fig. 5A). Spatial memory was studied in the Barnes Maze. In this test, 
mice are exposed to a round open space delimited by holes in the pe-
riphery, where only one of them is an escape hole. After repeated ses-
sions, mice learn to find shelter in the escape hole using spatial cues 
placed in the periphery. During learning, NrxnCTF mice and control 
groups spent similar time to find the escape hole in the initial and the 
final fourth session, although the escape time in the second and third 
sessions was reduced in NrxnCTF mice (Fig. 5B). After learning, the 
escape hole is closed and spatial memory is evaluated one and eight days 
later. At both time points, NrxnCTF mice showed no differences with 
control groups in the time spent in the target quadrant (Fig. 5C, D). 
These data indicate that recognition and spatial memories are not 
affected in NrxnCTF mice. 
3.6. Decreased fear-conditioning memory in NrxnCTF mice 
We evaluated fear-memory, a form of associative learning depending 
on the amygdala and hippocampus (Kim and Fanselow, 1992; Phillips 
and LeDoux, 1992). In the fear-conditioning assay, mice learn by repe-
tition to associate a neutral stimulus, a tone (the conditioned stimulus, 
CS), with a behavioral significant stimulus co-terminating with the CS, a 
mild electric shock (the unconditioned stimulus, US). NrxnCTF mice 
showed no significant differences with controls during conditioning 
evaluated as the freezing time during CS-US pairing (Fig. 6A). Contex-
tual- and auditory-fear memory was evaluated one day after CS-US 
pairing. NrxnCTF mice showed similar freezing time than controls 
when exposed to the arena where CS-US stimuli were paired, indicating 
that NrxnCTF mice can evoke a freezing response (Fig. 6B). However, 
NrxnCTF mice showed reduced freezing time to the tone presented in a 
new arena (Fig. 6C). The reduced CS-dependent memory of NrxnCTF 
mice was not due to an effect of the CaMKIIα-tTA allele (Fig. 6C). These 
data indicate that expression of NrxnCTF in mature forebrain decreases 
associative fear memory. 
3.7. Altered short term synaptic plasticity at mPFC-BLA synapses of alert 
behaving NrxnCTF mice 
Cortical inputs from the mPFC regulate the expression of fear 
memories stored in the amygdala (Burgos-Robles et al., 2009; Corcoran 
and Quirk, 2007; Sotres-Bayon and Quirk, 2010). The presynaptic 
expression of NrxnCTF by cortical neurons along with the decrease in 
fear memory in NrxnCTF mice, pointed at mPFC-BLA synapses as an 
appropriate pathway to uncover potential synaptic effects caused by 






































































































Fig. 6. Decreased fear memory in NrxnCTF 
mice. A) Freezing time during the condi-
tioning session. Control 14.20 ± 3.37; 
CaMKIIα-tTA 20.17 ± 2.63; NrxnCTF 
14.87 ± 2.45. B) Freezing time in the 
context. Control 67.35 ± 14.98; CaMKIIα- 
tTA 90.30 ± 15.66; NrxnCTF 84.85 ±
16.47. C) Decreased freezing response dur-
ing tone presentation in NrxnCTF mice. 
Control 38.56 ± 4.99; CaMKIIα-tTA: 41.46 
± 7.35; NrxnCTF 19.04 ± 4.30. Control, n 
= 19; CaMKIIα-tTA, n = 13; NrxnCTF, n =
14. Time in s. * p < 0.05.   
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implanted with stimulating and recording electrodes in mPFC and BLA, 
respectively, for chronic fEPSP recordings (Fig. 7A, B). Wild-type and 
single transgenic mice were included in the same control group as no 
differential effects were detected in the previous experiments. The cor-
rect location of the electrodes was analyzed by histological procedures 
at the end of the recording sessions (Fig. 7C). The short latency (< 4 ms) 
and negative profiles of evoked fEPSPs (Fig. 8B) suggest that we were 
recording monosynaptic excitatory field responses evoked at mPFC-BLA 
synapses (Arruda-Carvalho and Clem, 2014; Hübner et al., 2014). 
First, we checked the general functional properties of the mPFC-BLA 
synapses by evoking fEPSP with paired-pulse (40 ms inter-stimulus) 
stimulation of increasing intensities (0.02–0.4 mA). Both control and 
NrxnCTF animals presented input/output curves with similar sigmoid- 
like profiles (Fig. 8A), suggesting that basal functional properties of 
mPFC-BLA synapses are not affected in NrxnCTF mice. 
To analyze short-term synaptic plasticity, we performed a paired- 
pulse ratio (PPR) test at different inter-stimulus intervals (10, 20, 40, 
100, 200 and 500 ms; F (5,45) = 6.718; P < 0.001). mPFC-BLA synapses of 
control mice presented a paired-pulse facilitation (PPF) with maximum 
facilitation at 20 ms (Fig. 8B). Interestingly, NrxnCTF mice lack facili-
tation at 20 ms and instead presented facilitation at the 100 ms inter- 
stimulus interval (Fig. 8B). These data indicate that accumulation of 
NrxnCTF delays the optimal range for synaptic facilitation at mPFC-BLA 
synapses. 
Last, we evoked LTP by the application of HFS in mPFC and 
recording of the effects in the BLA. LTP evolution in the BLA was 
recorded for 1 h the first day and for 30 min the three following days. As 
a result, both control (F (32, 252) = 8.555; P < 0.001) and NrxnCTF (F (32, 
226) = 4.255; P < 0.001) groups seemed to have significant LTP, espe-
cially in day one, that decreased in the following days (Fig. 9A). 
Nevertheless, there were no statistically significant differences between 
groups or pulses (1st or 2nd) (Fig. 9A). Interestingly, we noticed a dif-
ference in the PPF evoked by LTP in the two groups (Fig. 9B). The 
relationship between 2nd and 1st pulses has been reported as an indi-
cator for the presence of a presynaptic component of LTP (Madroñal 
et al., 2009). We calculated PPR following LTP induction with the 
following equation: (2nd pulse/1st pulse) x 100; and obtained the 
regression line for both groups (Fig. 9B). Control mice had a steeper 
(slope: 0.6143) regression line than NrxnCTF mice (slope: 0.3863) 
following LTP induction (equations and statistical values are shown in 
Fig. 9B). This suggests that NrxnCTF mice have a certain reduction in the 
presynaptic facilitation induced by the HFS protocol. Overall, the data 
collected from behaving mice in basal conditions and following the 
application of HFS indicate that accumulation of NrxnCTF impairs short- 
term synaptic plasticity. 
Fig. 7. Electrodes implantation. A) A bipolar stimulation electrode was implanted in the mPFC, and recording electrode was implanted in the BLA of the same 
hemisphere. A screw was fixed to the skull, serving as a ground. B) An illustration of two coronal slices from the mouse brain where the shaded areas indicate the 
location of the electrodes: red stands for the mPFC (up) and blue stands for the BLA (down). Diagrams and coordinates correspond to Franklin and Paxinos (2007). C) 
Representative micrographs of the electrode scar in mPFC (left) and BLA (right). (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
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4. Discussion 
PS function is crucial to maintain normal synaptic function and 
memory in mature brain. Causative mutations in PSEN genes lead to fAD 
by a loss of function mechanism, highlighting the need for the identifi-
cation of PS/gamma-secretase substrates of functional significance. Loss 
of PS function is commonly analyzed in approaches that result in the 
broad inhibition of the gamma-secretase proteolytic activity towards the 
full repertoire of substrates, limiting the functional validation of indi-
vidual candidates. By using adequate expression drivers, we recreated 
the accumulation of the Nrxn substrate for PS in adult forebrain neurons 
without affecting PS/gamma-secretase activity towards other substrates. 
We showed that NrxnCTF transgenic mice recapitulate the tissue dis-
tribution and the subcellular location of endogenously produced 
NrxnCTF caused by a loss of PS activity in the same forebrain regions. 
Importantly, NrxnCTF mice presented behavioral deficits, including 
decreased fear memory. Electrophysiological recordings at the mPFC- 
BLA synapses of alert behaving animals uncovered impaired presynap-
tic facilitation processes in NrxnCTF mice. Together, these data indicate 
that the impaired clearance of NrxnCTF may play a role in memory and 
synaptic plasticity deficits caused by a loss of PS function in fAD. 
The proteolytic processing of Nrxns has the ability to modulate the 
function of the synapse and, when altered, affect synapse physiology. 
The cleavage of the extracellular domain of Nrxn isoforms can regulate 
specific interactions with synaptic ligands (Peixoto et al., 2012; Suzuki 
et al., 2012), whereas the proteolytic clearing of the resulting NrxnCTF 
can avoid undesired interactions at the synapse (Servián-Morilla et al., 
2018). Currently, it is unknown if a specific subset of Nrxns participate 
in the generation of NrxnCTF in vivo. However, the cleavage of the 
specific ectodomain of Nrxn isoforms produces a common NrxnCTF 
because Nrxns share the transmembrane and cytoplasmic regions (Saura 
et al., 2011; Servián-Morilla et al., 2018). Based on these findings, we 
generated a transgene encoding the C-terminal residues of Nrxn1 
downstream of the ectodomain cleavage site that recreates the common 
NrxnCTF. We put special effort to direct the expression of NrxnCTF 
within a meaningful neuronal framework. The function of PS in mature 
brain has been extensively evaluated in PScKO mice, in which Cre- 
dependent deletion of PS genes was achieved in forebrain neurons by 
means of a CaMKIIα promoter (Saura et al., 2004). Similarly, we directed 
the expression of NrxnCTF to forebrain neurons by using an inducible 
system driven by a CaMKIIα promoter. Furthermore, the selection of an 
inducible system offers precise temporal control for the expression 
onset, which we initiated in adulthood (P > 30). We also generated 
PScKOtam mice in which inhibition of PS genes in forebrain neurons was 
initiated at P30, recreating the loss of PS genes reported in PScKO mice 
(Saura et al., 2004). By comparing NrxnCTF produced in transgenic mice 
and conditional PScKOtam mice, we showed that expression of trans-
genic NrxnCTF showed a tissue distribution in forebrain regions similar 
to the endogenously produced NrxnCTF in PScKOtam mice. Importantly, 
NrxnCTF mice presents normal PS1 levels and activity towards other 
gamma-secretase substrates, which opposed to the lack of PS expression 
and accumulation of substrates that occurs in PScKOtam mice. Moreover, 
NrxnCTF concentrates at presynaptic terminals of synaptosome prepa-
rations of transgenic mice, showing the same subcellular distribution 
previously reported for NrxnCTF in PScKO mice (Saura et al., 2011). 
Thus, the biochemical characterization validated the selective expres-
sion of a single PS/gamma-secretase substrate, NrxnCTF, in the mature 
forebrain. 
Functional characterization of NrxnCTF mice identified deficits in 
selected behavioral outcomes. NrxnCTF mice showed decreased repeti-
tive behavior in the self-grooming assay, mainly due to shorter duration 
of self-grooming events. In the three-chamber test, NrxnCTF mice pref-
erentially interacted with a mouse over an object as controls, although 
NrxnCTF mice showed a trend towards decreased social interaction. 
Mutations and deletions in NRXN1 gene have been found repeatedly in 
patients of neurodevelopmental disorders, including autism and 
schizophrenia (Camacho-Garcia et al., 2013; Camacho-Garcia et al., 
2012; Guilmatre et al., 2009; Rujescu et al., 2009; Szatmari et al., 2007). 
Interestingly, the performance of NrxnCTF mice in the self-grooming 
assay and in the three-chamber test oppose to the increased repetitive 
behavior and impaired social interaction found in an autism-associated 
mouse model expressing a Nrxn1 mutant thought to work in a dominant- 
negative way (Rabaneda et al., 2014). The expression of both Nrxn 
transgenes in these two mouse models was achieved using the same 
CaMKIIα-tTA driver. These data suggest that the defects caused by 




































































Fig. 8. Input/output curves and PPF evoked at mPFC-BLA synapses in control and NrxnCTF mice. A) Input/output (I/O) curves from control (black) and NrxnCTF 
(red) mice for both 1st (open circles) and 2nd (closed circles) pulses. This test reported a similar progress of the fEPSP amplitude along increasing intensities (from 
0.02 mA to 0.4 mA in intervals of 0.02 mA) for both groups. Data are normalized as the percentage of the amplitude corresponding to the maximum intensity. Every 
point of each animal (n ≥ 7 per group) represents the mean value of 10 pulses. B) At the top are illustrated examples of fEPSP recordings from control and NrxnCTF 
mice during the PPF test, representative of the 3 time-intervals of maximum facilitation (20, 40, and 100 ms). Results of the PPF test for control (black) and NrxnCTF 
mice (red) are shown below. Data are represented as the ratio 2nd pulse/1st pulse of the fEPSP amplitude multiplied by 100, along increasing interstimulus intervals 
(10, 20, 40, 100, 200, and 500 ms). Every point of each animal (n = 10 per group) represents the mean value of 10 stimuli. * p < 0.05 in comparison with the values 
at 500 ms —the most similar to baseline values. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of 
this article.) 
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gain-of-function mechanism caused by the impaired clearance of 
NrxnCTF. 
Fear-conditioning memory was decreased in NrxnCTF mice. The 
specific defects in tone-dependent fear memory suggested that expres-
sion of NrxnCTF produces a malfunctioning of synaptic circuits relevant 
for this form of associative memory. Based on the presynaptic expression 
of NrxnCTF by cortical excitatory neurons and the crucial role of mPFC 
excitatory inputs to BLA in fear expression (Burgos-Robles et al., 2009; 
Corcoran and Quirk, 2007), we reasoned that mPFC-BLA synapses pro-
vide an informative framework to search for synaptic defects caused by 
NrxnCTF. Field EPSP recordings at mPFC-BLA synapses of alert 
behaving mice revealed specific defects at PPF in NrxnCTF mice. PPF is a 
form of short-term synaptic plasticity that is used as an indirect mea-
surement of changes in the probability of release of neurotransmitter at 
the presynaptic terminal (Lauri et al., 2007; Madroñal et al., 2009; 
Zucker and Regehr, 2002). It is assumed that presynaptic components of 
LTP could modify the PPF ratio by affecting the mechanism of trans-
mitter release (Andreescu et al., 2007). In contrast, the post-synaptic 
form of the LTP will not affect the PPF ratio, because those changes 
are assumed to take place at the post-synaptic site (Andreescu et al., 
2007; Madroñal et al., 2009; Zucker and Regehr, 2002). 
In control mice, mPFC-BLA synapses showed maximum facilitation 
at 20 ms inter-stimulus interval. However, NrxnCTF mice failed to 
facilitate at this short interval and instead presented facilitation at 100 
ms. Facilitation is mediated by presynaptic changes in residual calcium 
following a previous closely-spaced stimulus (Katz and Miledi, 1968; 
Thomson, 2000; Zucker and Regehr, 2002). Notably, we have previously 
found that expression of NrxnCTF decreases activity-dependent calcium 
influx and neurotransmitter release in cultured neurons (Servián-Morilla 
et al., 2018), pointing at altered calcium signaling as a potential 
mechanism affected in NrxnCTF mice. Analysis of PPR induced by HFS 
further supported a deleterious role of NrxnCTF in short-term synaptic 
plasticity. We found that HFS produced LTP in mPFC-BLA synapses of 
control mice that peaked at day one and decayed in the following days. 
PPF did not change during LTP expression, suggesting a postsynaptic 
component, but PPF increased following LTP, indicating a dynamic 
change in the probability of release. The induction of LTP at mPFC-BLA 
synapses of NrxnCTF mice was found of similar magnitude and duration 
than controls. However, the increase in PPF following LTP was reduced 
in NrxnCTF mice as compared with controls. Interestingly, synaptic 
facilitation transiently increases in the hippocampus of behaving mice 
during the acquisition of an associative learning paradigm (Madroñal 
et al., 2009). In cortical afferents to BLA, modification of release prob-
ability underlies the expression of homosynaptic and heterosynaptic LTP 
in slice preparations (Huang and Kandel, 1998; Humeau et al., 2003). 
These data suggest that the presynaptic accumulation of NrxnCTF might 
alter a mechanism important for dynamic changes in release probability 
and synaptic facilitation related to associative memory. 
When comparing the phenotype of NrxnCTF mice with the behav-
ioral and synaptic alterations in PScKO mice, several points arise. The 
impaired fear memory of NrxnCTF mice resembles the deficits found in 
tone-dependent fear memory of PScKO mice, but spatial and recognition 
memory are only affected in PScKO mice and spared in NrxnCTF mice 
(Cao et al., 2018; Feng et al., 2004; Saura et al., 2004). It is not currently 
known if these differences arise from a role of NrxnCTF exclusively 
affecting circuits important for fear memory or from differences in the 
experimental conditions. As an example, spatial memory has been 
explored in PScKO mice using the Morris Water Maze, a more stressful 
test for mice than the Barnes Maze used in this study (Harrison et al., 
2009). Furthermore, ongoing neurodegeneration can likely affect the 
performance of memory tests when analyzed in aged mice (Feng et al., 
2004). At the synaptic level, PS activity is essential to regulate short- 
term plasticity acting through several mechanisms that depend on the 
identity of the synapse under study. Deletion of PS1/2 impairs synaptic 
facilitation and short-term plasticity in hippocampal neurons through a 
presynaptic mechanism that depends on calcium release from the 
endoplasmic reticulum at CA3-CA1 synapses or from the mitochondria 
at dentate gyrus (DG)-CA3 synapses (Lee et al., 2017; Zhang et al., 
2009). In addition, PS1/2 genes in hippocampal DG neurons are 
required to maintain the levels of the calcium sensor synaptotagmin-7, a 
presynaptic protein important for synaptic facilitation (Barthet et al., 
2018). Genetic deletion of APP in DG neurons lacking PS1 gene rescues 
synaptotagmin-7 levels and normalizes short-term plasticity at DG-CA3 
synapses, suggesting a functional contribution of APP-CTF (or APP) in 
the short-term plasticity defects caused by inactivation of PS (Barthet 
et al., 2018). The synaptic mechanism underlying impaired fear memory 
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Fig. 9. Differences in LTP evoked at mPFC-BLA synapses in control and 
NrxnCTF mice. A) At the top are illustrated representative examples of fEPSP 
recordings collected during LTP induction in control (left) and NrxnCTF (right) 
mice. Arrows point to 1st and 2nd stimuli. BL: baseline, D1 and D4: 1st and 4th 
day after the HFS session. The LTP evoked in the BLA after the HFS applied to 
the mPFC is represented below. Black symbols stand for control mice and red 
ones stand for NrxnCTF mice. The effects of 1st (circles) and 2nd (dots) pulses 
are plotted. LTP effect was quantified during 4 days after the induction and is 
shown as a percentage of the 1st pulse of baseline amplitude. Every point of 
each animal (n = 9 animals/ group) represents the mean value of 15 pulses for 
each 5 min interval. St1: 1st stimulus and St2: 2nd stimulus. B) Linear regres-
sion analysis following LTP. The control group (black dots and line) presented a 
linear regression line with a stepper slope (0.6143 vs. 0.3863) than in the 
NrxnCTF group (red dots and line). (For interpretation of the references to 
colour in this figure legend, the reader is referred to the web version of 
this article.) 
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indicating that NrxnCTF impairs synaptic facilitation at mPFC-BLA 
synapses are consistent with a broad role of PS in the regulation of 
short-term plasticity in AD (Barthet and Mulle, 2020). It remains to be 
investigated whether NrxnCTF affects short-term plasticity in other 
forebrain regions where it accumulates upon inactivation of PS genes, 
such as the hippocampus. 
Collectively, our study demonstrates that failure in the synaptic 
clearance of NrxnCTF results in defects in short-term synaptic plasticity 
and associative memory. Because defects in synaptic facilitation and 
fear-conditioning memory are early effects caused by the inactivation of 
PS (Saura et al., 2004), the data shown here point at NrxnCTF as a 
relevant mediator related to the inhibition of PS function. The discovery 
of new players with a functional impact in the loss of PS function may 
represent an important step in AD. Furthermore, it is unlikely that a 
single PS/gamma-secretase substrate will explain the plethora of deficits 
caused by a loss of PS function, highlighting the participation of multiple 
mediators with functional relevance at specific roles. Our data suggest 
that NrxnCTF is a novel player that can participate in the synaptic and 
memory deficits associated with a loss of PS function in AD. 
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